We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-13.83%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.51B
AUM Growth
-$1.01B
Cap. Flow
+$139M
Cap. Flow %
2.14%
Top 10 Hldgs %
20.49%
Holding
891
New
87
Increased
331
Reduced
275
Closed
84

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$60.9M
2
VRTX icon
Vertex Pharmaceuticals
VRTX
+$30.7M
3
BIIB icon
Biogen
BIIB
+$19.7M
4
MA icon
Mastercard
MA
+$18.7M
5
BMY icon
Bristol-Myers Squibb
BMY
+$18M

Top Sells

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$32.8M
2
EC icon
Ecopetrol
EC
+$29.1M
3
AET
Aetna Inc
AET
+$20.2M
4
XOM icon
ExxonMobil
XOM
+$19.6M
5
AMGN icon
Amgen
AMGN
+$19.2M

Sector Composition

Rank Sector Weight
1 Healthcare 35.31%
2 Technology 15.37%
3 Financials 11.61%
4 Consumer Discretionary 8.19%
5 Communication Services 7.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
KURA icon
276
Kura Oncology
KURA
$929M
$5.14M 0.08%
366,000
– –
D icon
277
Dominion Energy
D
$62B
$5.11M 0.08%
71,536
+12,877
+22% +$941K
TFCFA
278
DELISTED
Twenty-First Century Fox, Inc. Class A
TFCFA
$5.1M 0.08%
106,033
-1,700
-2% -$80.6K
RARE icon
279
Ultragenyx Pharmaceutical
RARE
$2.67B
$5.02M 0.08%
115,500
+2,400
+2% +$131K
RDUS
280
DELISTED
Radius Health, Inc.
RDUS
$5.01M 0.08%
304,025
– –
BNY
281
Bank of New York Mellon
BNY
$107B
$4.95M 0.08%
105,221
+21,925
+26% +$1.06M
IMGN
282
DELISTED
Immunogen Inc
IMGN
$4.9M 0.08%
1,021,139
+68,639
+7% +$416K
EXC icon
283
Exelon
EXC
$48.5B
$4.88M 0.08%
151,744
+20,399
+16% +$652K
SU icon
284
Suncor Energy
SU
$75.9B
$4.87M 0.07%
174,573
+27,478
+19% +$913K
CSX icon
285
CSX Corp
CSX
$95.8B
$4.84M 0.07%
233,838
+22,449
+11% +$516K
APC
286
DELISTED
Anadarko Petroleum
APC
$4.84M 0.07%
110,436
+4,081
+4% +$230K
DRNA
287
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$4.78M 0.07%
447,500
+156,000
+54% +$2.05M
RVNC
288
DELISTED
Revance Therapeutics, Inc.
RVNC
$4.77M 0.07%
237,000
+66,000
+39% +$1.45M
MRO
289
DELISTED
Marathon Oil Corporation
MRO
$4.7M 0.07%
327,570
+73,166
+29% +$1.31M
TRP icon
290
TC Energy
TRP
$71.5B
$4.66M 0.07%
130,634
+858
+0.7% +$33.8K
PGR icon
291
Progressive
PGR
$126B
$4.66M 0.07%
77,212
-116,923
-60% -$7.78M
VNDA icon
292
Vanda Pharmaceuticals
VNDA
$318M
$4.65M 0.07%
+178,000
New +$4.19M
GG
293
DELISTED
Goldcorp Inc
GG
$4.65M 0.07%
474,513
+7,079
+2% +$68.7K
EOG icon
294
EOG Resources
EOG
$76.1B
$4.55M 0.07%
52,132
-640
-1% -$68.5K
DNB
295
DELISTED
Dun & Bradstreet
DNB
$4.54M 0.07%
+31,800
New +$4.53M
AFL icon
296
Aflac
AFL
$64.4B
$4.51M 0.07%
99,018
-5,530
-5% -$246K
SUPN icon
297
Supernus Pharmaceuticals
SUPN
$2.75B
$4.49M 0.07%
+135,000
New +$5.81M
AHL
298
DELISTED
ASPEN Insurance Holding Limited
AHL
$4.48M 0.07%
106,600
– –
TU icon
299
Telus
TU
$16.3B
$4.47M 0.07%
269,600
+4,802
+2% +$83.6K
ANAB icon
300
AnaptysBio
ANAB
$1.61B
$4.46M 0.07%
70,000
– –
10 11
12
13 14

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q4 2018 Portfolio in Review

As of Q4 2018, Candriam SCA held 891 positions worth $6.51B, down 13% from $7.52B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Candriam SCA's Q4 2018 filing shows 87 new, 331 increased, 275 reduced and 84 closed positions. Its largest new stake was Azul: 501,000 shares worth $13.9M. The largest sale was TESARO, Inc., an estimated $32.8M.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 33% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q4 2018 buy was Azul: 501,000 shares worth $13.9M.
  • Candriam SCA added most to Celgene Corp in Q4 2018, an estimated $60.9M increase.
  • Candriam SCA's biggest Q4 2018 reduction was TESARO, Inc., cutting an estimated $32.8M.
  • Candriam SCA fully exited Aetna Inc in Q4 2018, selling an estimated $20.2M.
  • Candriam SCA's ten largest holdings make up 20% of its $6.51B portfolio in Q4 2018.
  • Candriam SCA opened 87 new positions and closed 84 in Q4 2018.
  • Candriam SCA's portfolio value fell 13% quarter-over-quarter to $6.51B.

Based on Candriam SCA's 13F filing for Q4 2018, filed 14 Feb 2019.